These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 8877676)

  • 61. Pharmacokinetics and body distribution of amiodarone in man.
    Plomp TA; van Rossum JM; Robles de Medina EO; van Lier T; Maes RA
    Arzneimittelforschung; 1984; 34(4):513-20. PubMed ID: 6540111
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Intravenous amiodarone for the pharmacological termination of haemodynamically-tolerated sustained ventricular tachycardia: is bolus dose amiodarone an appropriate first-line treatment?
    Tomlinson DR; Cherian P; Betts TR; Bashir Y
    Emerg Med J; 2008 Jan; 25(1):15-8. PubMed ID: 18156531
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Pharmacokinetics, antiarrhythmic effects, and tissue concentrations of amiodarone and desethylamiodarone in dogs with acute coronary artery occlusion.
    Somani P; Simon VA; McManus K
    Can J Cardiol; 1985 Jan; 1(1):56-65. PubMed ID: 3850764
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effect of relatively low dose amiodarone therapy on left ventricular function in patients with ventricular tachyarrhythmias.
    Yamada S; Yamaguchi I
    Jpn Circ J; 1998 Sep; 62(9):707-9. PubMed ID: 9766713
    [TBL] [Abstract][Full Text] [Related]  

  • 65. [Combination of celiprolol and amiodarone in the treatment of recurrent ventricular tachycardia].
    Tonet J; Hidden F; Naditch L; Coutte R; Himbert C; Frank R
    Ann Cardiol Angeiol (Paris); 1996 Jan; 45(1):18-23. PubMed ID: 8815771
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Pharmacokinetics and pharmacodynamic effects of amiodarone in plasma of ponies after single intravenous administration.
    Trachsel D; Tschudi P; Portier CJ; Kuhn M; Thormann W; Scholtysik G; Mevissen M
    Toxicol Appl Pharmacol; 2004 Feb; 195(1):113-25. PubMed ID: 14962511
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Intravenous amiodarone for recurrent sustained hypotensive ventricular tachyarrhythmias. Intravenous Amiodarone Multicenter Trial Group.
    Levine JH; Massumi A; Scheinman MM; Winkle RA; Platia EV; Chilson DA; Gomes A; Woosley RL
    J Am Coll Cardiol; 1996 Jan; 27(1):67-75. PubMed ID: 8522712
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Intravenous amiodarone.
    Med Lett Drugs Ther; 1995 Dec; 37(963):114-5. PubMed ID: 7500909
    [No Abstract]   [Full Text] [Related]  

  • 69. Potential cost-effectiveness of prophylactic use of the implantable cardioverter defibrillator or amiodarone after myocardial infarction.
    Sanders GD; Hlatky MA; Every NR; McDonald KM; Heidenreich PA; Parsons LS; Owens DK
    Ann Intern Med; 2001 Nov; 135(10):870-83. PubMed ID: 11712877
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Intravenous amiodarone for incessant tachyarrhythmias in children: a randomized, double-blind, antiarrhythmic drug trial.
    Saul JP; Scott WA; Brown S; Marantz P; Acevedo V; Etheridge SP; Perry JC; Triedman JK; Burriss SW; Cargo P; Graepel J; Koskelo EK; Wang R;
    Circulation; 2005 Nov; 112(22):3470-7. PubMed ID: 16316969
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Pharmacokinetics of intravenous amiodarone in children.
    Ramusovic S; Läer S; Meibohm B; Lagler FB; Paul T
    Arch Dis Child; 2013 Dec; 98(12):989-93. PubMed ID: 24051016
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Amiodarone in patients with congestive heart failure and asymptomatic ventricular arrhythmia. Survival Trial of Antiarrhythmic Therapy in Congestive Heart Failure.
    Singh SN; Fletcher RD; Fisher SG; Singh BN; Lewis HD; Deedwania PC; Massie BM; Colling C; Lazzeri D
    N Engl J Med; 1995 Jul; 333(2):77-82. PubMed ID: 7539890
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Hemodynamic profile of amiodarone during acute and long-term administration in patients with ventricular dysfunction.
    Remme WJ; van Hoogenhuyze DC
    Cardioscience; 1990 Sep; 1(3):169-76. PubMed ID: 2102806
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Dose-ranging study of intravenous amiodarone in patients with life-threatening ventricular tachyarrhythmias. The Intravenous Amiodarone Multicenter Investigators Group.
    Scheinman MM; Levine JH; Cannom DS; Friehling T; Kopelman HA; Chilson DA; Platia EV; Wilber DJ; Kowey PR
    Circulation; 1995 Dec; 92(11):3264-72. PubMed ID: 7586313
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Important differences between short- and long-term hemodynamic effects of amiodarone in patients with chronic ischemic heart disease at rest and during ischemia-induced left ventricular dysfunction.
    Pfisterer M; Burkart F; Müller-Brand J; Kiowski W
    J Am Coll Cardiol; 1985 May; 5(5):1205-11. PubMed ID: 3989133
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Impact of concurrent amiodarone treatment on the tolerability and efficacy of carvedilol in patients with chronic heart failure.
    Macdonald PS; Keogh AM; Aboyoun C; Lund M; Amor R; McCaffrey D
    Heart; 1999 Nov; 82(5):589-93. PubMed ID: 10525515
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Intravenous amiodarone in the treatment of refractory life-threatening cardiac arrhythmias in the critically ill patient.
    Leak D
    Am Heart J; 1986 Mar; 111(3):456-62. PubMed ID: 3953353
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Implantable cardioverter-defibrillators for treatment of sustained ventricular arrhythmias in patients with Chagas' heart disease: comparison with a control group treated with amiodarone alone.
    Gali WL; Sarabanda AV; Baggio JM; Ferreira LG; Gomes GG; Marin-Neto JA; Junqueira LF
    Europace; 2014 May; 16(5):674-80. PubMed ID: 24481778
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Disposition of amiodarone and its proximate metabolite, desethylamiodarone, in the dog for oral administration of single-dose and short-term drug regimens.
    Brien JF; Jimmo S; Brennan FJ; Armstrong PW; Abdollah H
    Drug Metab Dispos; 1990; 18(6):846-51. PubMed ID: 1981527
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Old and new antiarrhythmic drugs for converting and maintaining sinus rhythm in atrial fibrillation: comparative efficacy and results of trials.
    Naccarelli GV; Wolbrette DL; Khan M; Bhatta L; Hynes J; Samii S; Luck J
    Am J Cardiol; 2003 Mar; 91(6A):15D-26D. PubMed ID: 12670638
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.